For-profit organizations · Montréal, Quebec
Giiant Pharma Inc.
- Total value
- $345K
- Agreements
- 1
- Programs
- 1
- First and latest
- 2021–2021
Federal grants and contributions, agreements starting Jan 2006 to Oct 2026, each counted once at its latest amended value. Source: Treasury Board proactive disclosure, published October 11, 2026. Agreements under programs that mostly fund individuals are not listed under any name.
See this recipient’s records on the government’s search
By program
| Program | Department | Agreements | Total |
|---|---|---|---|
| Industrial Research Assistance Program – Contributions to Firms | National Research Council Canada | 1 | $345K |
Agreements
Newest first.
| Start | Program | What for | Value |
|---|---|---|---|
| Aug 2021 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | The development of digestive tract-circumscribed PDE4 inhibitor prodrugs for the treatment of ulcerative colitis.Contribution | $345,000 |